Hepatitis prevention in the context of HIV prevention point work in Latvia
|
|
|
- Angela Warner
- 5 years ago
- Views:
Transcription
1 Hepatitis prevention in the context of HIV prevention point work in Latvia Līva Grāmatiņa Centre for disease prevention and control of Latvia
2 HIV prevention point network in Latvia: History; Location; Financing and legal status; Types of service; Target groups; Data collection. Hepatitis B and C prevention: Hepatitis B and C prevalence in risk groups; Hepatitis B and C rapid testing results; Rapid testing algorithm; World Hepatitis day activities
3 HIV prevention point network and harm reduction in Latvia 3
4 History of HIV prevention point services in Latvia In 997 first needle exchange programme (NEP) in Riga In first outreach workers were involved in prevention activities In 2000 NEP was extended to two other cities In 2002 new 8 NEP (external funding) In 204 one new HPP opened(ventspils city) In the beginning of The Checkpoint (for men who have sex with men (MSM)) 205- there are 9 HIV prevention services in 6 cities in Latvia. Including 3 mobile units, outreach work in 7 cities. 4
5 9 HPP in 6 municipalities - Municipalities where is HPP 5
6 Legal status of HPP and financing agreements Municipalities Coordinator HIV/AIDS CR GO budget Project budget Methodological guidance Trainings Data analysis NGO s Coordinators of municipalities Municipalities budget Project budget Services for clients (testing, counseling etc) Salaries for staff Data collection Medical facilities (rapid tests, syringes, disinfectants, condoms etc.) Public utilities payments 6
7 HIV prevention point - types of service Fixed place for service (HIV/AIDS consulting room); Mobile unite programme (minibuses); Outreach work programme. 7
8 HIV prevention point in Ogre
9 Target groups of HIV prevention services.drug-users Users of opiates; Users of cocaine and stimulants; Women drug-users; Minor drug-users; Ex-prisoners drug-users; Persons who involved in commercial sex drug-users and etc. 2.Men who have sex with men 3.Persons with other addiction problems 9
10 HIV prevention services for IDU'S and other HIV risk groups. Needle and syringe exchange 2. Supply with disinfectants, condoms and other medical facilities 3. Counselling and information (medical worker, social worker, psychologist) about: drug adiction treatment and rehabilitation; health risks related to drug injection and safe drug injection practice; social support; infectious disease and prevention measures; psychological support; counselling of family members and partners. 4. Rapid testing: HIV, HBV, HCV, syphilis 0
11 Data collection - electronic data base (202) Demographic information: Gender, age, nationality, education level. Injecting behaviour: Ever, how often, last drug use. Status: IDU, SW, ex-prisoner, pregnancy, HIV+ etc. Consultation: infectious disease, STI, motivation, rehabilitation, treatment etc. Medical facilities: performed rapid tests, distributed syringes,needles, condoms etc.
12 Hepatitis B and C prevention 2
13 Hepatitis B and C prevalence in the HIV risk groups (study results) Risk group Prevalnce of hepatitis B Prevalence of hepatitis C Year Reaserch Drug users 3,0% 83,7% 203 7th wave of Riga Drug User s Cohort Study (RDUCS) Drug users 2,4% 83,3% 202 6th wave of Riga Drug User s Cohort Study (RDUCS) Sex workers 47,0% 58,% 202 «HIV infection, other infections and associated risk factor identification in one of the HIV infection risk group commercial sex workers» Prisoners 7,0%* 34,0%* 204 «Research on drug prevalence in prisons of Latvia in 204» *during the last year of those prisoners who carried out the blood test 3
14 Rapid testing algorithm in HIV prevention points Pre-test counselling: a) testing experience; b) reason of testing/ process / «window period»; c) risk assessment of infection; d) information / education / prevention regarding hepatitis Client s informed consent Rapid testing - + Post-test counselling Health risks Retesting after time («window» period) Post-test counselling Implecations of positive test result; Confirmatory diagnostic (Infectology centre); Psyhological and emotianl support. 30 minutes 4
15 Hepatits B rapid testing results in HIV prevention points, (drug users) P=,5% P=2,% P=2,0% P=3,7% 5
16 Hepatits C rapid testing results in HIV prevention points, (drug users) P=54,4% P=59,2% P=72,9% P=29,0% P=37,9% 6
17 Hepatitis prevention activities in HIV prevention points» World Tuberculosis day (24 March);» World Hepatitis day (28 July);» HIV testing week (one week before World AIDS day);» World AIDS day ( December). 7
18 World Hepatitis day activities 205 (27 July August) Open days in HIV prevention points (0) and in Red Cross of Latvia Health rooms (2); Rapid testing activities (hepatitis, HIV, syphilis); Specialist consultations about heaptitis and other infections; Passing out flyers; Information in social networks (facebook, twitter, homepages); Informative materials. Performed: 04 Hepatits C rapid tests (+49) 390 Hepatitis B rapid tests (+6) 224 HIV rapid tests (+) 9 Syphilis rapid tests (+) 8
19 Informative materials Flayer Fact sheet in social network Testing calendar 9
20 Informative materials Booklet HIV/AIDS, hepatitis B and C, STI s Brochure hepatitis C Posters 2 0
21 THANK YOU
Review on HIV & Associated Infections in Latvia
Review on HIV & Associated Infections in Latvia Dr.Inga Upmace, Infectology Center of Latvia Second meeting on EG on HIV/AIDS and AI April 7, 2011, Riga Negative influences: Several reorganizations of
Feedback from joint country mission on HIV and hepatitis B and C of ECDC and EMCDDA experts to Latvia, September 2014
Feedback from joint country mission on HIV and hepatitis B and C of ECDC and EMCDDA experts to Latvia, September 2014 Dr. Nicole Werner-Keišs Lisbon, 16.10.2014 Outline Background, scope and objectives
Trends of HIV/AIDS in LATVIA. Inga Upmace, Infectology Center of Latvia, AIDS Program Department Saariselka,
Trends of HIV/AIDS in LATVIA Inga Upmace, Infectology Center of Latvia, AIDS Program Department Saariselka,15.-16.03.2010 Main tasks of our department: To coordinate HIV restriction policy implementation
The Comprehensive Package: The simple truth about our response to drug related HIV. Dr. Monica Beg, Signe Rotberga UNODC
The Comprehensive Package: The simple truth about our response to drug related HIV Dr. Monica Beg, Signe Rotberga UNODC HIV among injecting drug users Why is it so important? 30% global HIV infections
NEEDLE AND SYRINGE PROGRAMMES MONITORING IN LITHUANIA
NEEDLE AND SYRINGE PROGRAMMES MONITORING IN LITHUANIA Dr. Audronė Astrauskienė Drug control department under the Government of the Republic of Lithuania 2010 10 25 Harm reduction services development in
Improving Access to Test and Counselling Services for Injection Drug Users: Most Recent Experience from Portugal. Henrique Barros
Improving Access to Test and Counselling Services for Injection Drug Users: Most Recent Experience from Portugal Henrique Barros Ministério da Saúde HIV Testing Knowledge of HIV serostatus has been increasingly
The evolution of the HIV/AIDS outbreak among IDUs in Romania
The evolution of the HIV/AIDS outbreak among IDUs in Romania Romanian National Antidrug Agency Romanian National Focal Point on Drugs Andrei Botescu * Lisbon, 12 th October 2012 HIV outbreak among IDU
Technical Guidance Note for Global Fund HIV Proposals
Technical Guidance Note for Global Fund HIV Proposals UNAIDS I World Health Organization I 2011 Rationale for including this activity in the proposal The World Health Organization (WHO), the Joint United
NSPs in Estonia: current situation and future challenges
NSPs in Estonia: current situation and future challenges Aljona Kurbatova National Institute for Health Development Riga, 25.10.2010 1 Background First NSP project was launched in May 1997 needle and syringe
The new German strategy on HIV, Hepatitis B, C and STI, an integrated approach. Ines Perea Ministry of Health, Germany
The new German strategy on HIV, Hepatitis B, C and STI, an integrated approach Ines Perea Ministry of Health, Germany Reasons for a new strategy in 2016 New international agreements (SDG s) Renewed political
KAZAKHSTAN. National Focal Point. Drug Abuse and Drug Dependence Treatment Situation. Territory : 2,717,300 km 2 Capital: Astana BASIC DATA
KAZAKHSTAN Territory : 2,717,300 km 2 Capital: Astana Map No. 3771 Rev. 6 UNITED NATIONS January 2004 BASIC DATA Total population (millions) 2009 15.5* Population under age15 (as % of total) 2010 23.8*
HIV epidemic around the Baltic Sea
HIV epidemic around the Baltic Sea Pauli Leinikki National Public Health Institute Subtitles Statistics: what seems to have happened Dynamics: in what order Dissection: what actually happened Target friendly
2 nd Meeting on detecting and responding to outbreaks of HIV among PWID
2 nd Meeting on detecting and responding to outbreaks of HIV among PWID Update on country situation: ROMANIA Adrian Abagiu* & Andrei Botescu** *Romanian Association Against AIDS (ARAS) and National Institute
ANNUAL PROJECT PROGRESS REPORT FOR 2008 (draft)
ANNUAL PROJECT PROGRESS REPORT FOR 2008 (draft) Project Title: HIV/AIDS prevention and care among injecting drug users and in prison settings in Estonia, Latvia and Lithuania Project Number: XEEJ20 Total
Prevention and control of Hepatitis B and C among vulnerable groups Estonia: People who use drugs
Prevention and control of Hepatitis B and C among vulnerable groups Estonia: People who use drugs Aljona Kurbatova National Institute for Health Development Estonia Estimated number of people who inject
UNGASS COUNTRY PROGRESS REPORT LATVIA
UNGASS COUNTRY PROGRESS REPORT LATVIA Reporting period: January 2008 December 2009 Submission date: March 31, 2010 TABLE OF CONTENTS TABLE OF CONTENTS 1 I. ABBREVIATIONS 2 II. STATUS AT GLANCE 4 III. OWERVIEW
THE PORTUGUESE COMMUNITY SCREENING NETWORK
THE PORTUGUESE COMMUNITY SCREENING NETWORK COBATEST Annual Network Meeting 14 May 2018 Presented by: Name goes here Paula Meireles, on behalf of the Community Screening Network EPIUnit ISPUP FUNDING (from
COUNTRY REPORT: EPIDEMIOLOGICAL SITUATIONS AND PROJECT ACTIVITIES
COUNTRY REPORT: EPIDEMIOLOGICAL SITUATIONS AND PROJECT ACTIVITIES BIRUTE SEMENAITE, MEDICAL DIVISION OF PRISON DEPARTMENT AT THE MINISTRY OF JUSTICE OF THE REPUBLIC OF LITHUANIA LITHUANIAN PRISONS. BACKGROUND:
Additional North Carolina Projects
Additional North Carolina Projects William Zule, Dr.P.H. www.rti.org RTI International is a trade name of Research Triangle Institute Risk Groups Injecting drug users (IDUs) Non-injecting drug users (non-idus)
NDPHS Expert Group on HIV/AIDS and Associated Infections Progress report 27 October, Chair Dr. Ali Arsalo and ITA Ms Outi Karvonen
NDPHS Expert Group on HIV/AIDS and Associated Infections Progress report 27 October, 2011 Chair Dr. Ali Arsalo and ITA Ms Outi Karvonen NDPHS Goals for the HIV/AIDS & AI Expert Group Goal 2: Prevention
COUNTRY TABLE. MONTENEGRO.
EPIDEMIOLOGICAL DATA Indicator Data Source of data/additional notes re data Year of estimate Population 620 029 National Census data 2011 Estimated number of people who inject drugs (PWID) 1282 (95%CI
Models of good practice in drug treatment in Europe. Project group
Models of good practice in drug treatment in Europe ( moretreat 2006329 ) Project group Hamburg, London, Rome, Stockholm, Vienna, Warsaw, Zurich Project duration: 17 months from April 2006 August 2008
Tajikistan National Report. Summary HARM REDUCTION WORKS FUND IT! Arguments for strategic investment. Summary of National Report: Tajikistan
HARM REDUCTION WORKS FUND IT! National Report Summary Arguments for strategic investment With the support of The present document contains a summary of the key conclusions and recommendations provided
Harms and harm reduction workbook. Country X
Harms and harm reduction workbook Country X 1 Table of Contents T0. Summary... 3 T1. National profile... 3 T1.1 Drug-related deaths... 3 T1.2 Drug related acute emergencies... 4 T1.3 Drug related infectious
Government of Canada Federal AIDS Initiative Milestones
HIV in Canada: Trends and Issues for Advancing Prevention, Care, Treatment and Support Through Knowledge Exchange Michael R Smith, Senior Policy Advisor, Programs and Coordination Division, Centre for
TB: INTEGRATION IN HARM REDUCTION PACKAGES. ICF "AIDS Foundation East-West (AFEW Ukraine) Tbilisi, 2015
TB: INTEGRATION IN HARM REDUCTION PACKAGES ICF "AIDS Foundation East-West (AFEW Ukraine) Tbilisi, 2015 Ʃ = 185 760 «D» 45 083 / 38 126 TB Epidemiology in Ukraine Active TB prevalence in Ukraine (per 100,
Methods: respondent driven sampling (RDS) was used to recruit PWID
RDS study among PWID in Kohtla-Järve, north-east of Estonia: prevalence of HIV and risk behaviours (an update, based on 216 study, and methodological considerations) Maris Salekešin Sigrid Vorobjov Methods:
Strategies of drug users to avoid infection with hepatitis C
With financial support from the Drug Prevention and Information Programme of the European Union Strategies of drug users to avoid infection with hepatitis C Results from five European countries Dr. Heike
January Treatment Centre. December Drop-In Centre. November Regional Office
Dristi Nepal (By and for female drug users organization in Nepal) Di Dristi inepal was the first organization i to be established by and for female drug user s to deliver services in Nepal. We are based
Overview of Evidence for Sterile Syringe Access. Hilary McQuie Western Director Harm Reduction Coalition
Overview of Evidence for Sterile Syringe Access Hilary McQuie Western Director Harm Reduction Coalition Working Definition of Harm Reduction Harm Reduction: A set of practical, public health strategies
ATLAS on substance use 2017:
WHO Forum on alcohol, drugs and addictive behaviours Enhancing public health actions through partnerships and collaboration ATLAS on substance use 17: resources for the prevention and treatment of substance
epidemic among vulnerable groups
Project TUBIDU Empowering public health system and civil society to fight tuberculosis epidemic among vulnerable groups Prepared by: Aljona Kurbatova, NIHD Maarja Sukles, NIHD Liga Rusmane, LTBF What is
ALASKA NATIVE MEDICAL CENTER SEXUALLY TRANSMITTED DISEASE SCREENING AND TREATMENT GUIDELINES
ALASKA NATIVE MEDICAL CENTER SEXUALLY TRANSMITTED DISEASE SCREENING AND TREATMENT GUIDELINES A. Screening Page Chlamydia and Gonorrhea 1 HIV 1 Syphilis 1 Genital Herpes 2 Hepatitis A 2 Hepatitis B 2 Hepatitis
HIV and Hepatitis C Infection among Persons who Inject Drugs: Global Overview and Policy Implications
HIV and Hepatitis C Infection among Persons who Inject Drugs: Global Overview and Policy Implications Don Des Jarlais, Ph.D. Professor of Psychiatry, Icahn School of Medicine at Mount Sinai UNODC 2014
Drug Policy and the HIV Movement. SAULIUS CAPLINSKAS MD, PhD
Drug Policy and the HIV Movement SAULIUS CAPLINSKAS MD, PhD Director, Lithuanian AIDS Centre Assoc. Prof., Mykolas Romeris University 14th ECAD Mayors Conference Fighting Against Drugs - From Different
New EU Health Programme: funding mechanisms for civil society working on HIV and related areas
New EU Health Programme: funding mechanisms for civil society working on HIV and related areas Cinthia Menel Lemos Think Tank meeting Luxembourg, 10 December 2013 Executive Agency for Health and Consumers
World Health Organization. A Sustainable Health Sector
World Health Organization A Sustainable Health Sector Response to HIV Global Health Sector Strategy for HIV/AIDS 2011-2015 (DRAFT OUTLINE FOR CONSULTATION) Version 2.1 15 July 2010 15 July 2010 1 GLOBAL
Preventing Harm from Substance Use: Harm Reduction. July 6, Dr. Murray Fyfe Medical Health Officer Vancouver Island Health Authority
Preventing Harm from Substance Use: Harm Reduction July 6, 2009 Dr. Murray Fyfe Medical Health Officer Vancouver Island Health Authority Substance Dependence Substance use spans from abstinence, to beneficial
The Imp.Ac.T.project. Improving Access to HIV/TB Testing for marginalized groups
The Imp.Ac.T.project Improving Access to HIV/TB Testing for marginalized groups Presentation at DRID meeting EMCDDA 11 Oct. 2012 -Jenneke van Ditzhuijzen Acknowledgments: The Project Imp.Ac.T. Improving
QuADS Organisational Standards and Professional Competencies in needle exchange
QuADS Organisational Standards and Professional Competencies in needle exchange N This briefing paper was funded by the Department of Health as part of their 'Making Harm Reduction Work' initiative. DrugScope/Department
The role of UNODC in working law enforcement agencies to promote harm reduction. IHRC, Bangkok, 23 April 2009
The role of UNODC in working law enforcement agencies to promote harm reduction IHRC, Bangkok, 23 April 2009 Drug control has focused mostly on law enforcement Public health which is the first principle
HIV/AIDS INDICATORS. AIDS Indicator Survey 8 Basic Documentation Introduction to the AIS
HIV/AIDS INDICATORS During the last decade there has been an increased effort to track the progress in the area of HIV/AIDS. A of international agencies and organizations have developed indicators designed
STI and HIV Prevention and Care among Sex Workers
Training Course in Sexual and Reproductive Health Research 2017 Module: Sexually transmitted infections, HIV/AIDS STI and HIV Prevention and Care among Sex Workers Annette Verster and Michelle Rodolph
SAULIUS ČAPLINSKAS MD, PhD
Lithuanian experience in organization of intersectoral respose to HIV SAULIUS ČAPLINSKAS MD, PhD Director, Lithuanian AIDS Centre Assoc. Prof., Mykolas Romeris University, Vilnius, Lithuania www.aids.lt
Summary Report: Survey of Hepatitis C Virus counseling and testing services at HIV counseling and testing sites, and health service sites.
Summary Report: Survey of Hepatitis C Virus counseling and testing services at HIV counseling and testing sites, and health service sites. Sharon Adler MD, MPH Tomás Aragón MD, MPH Preventive Medicine
Primary and secondary hepatitis prevention and control programmes The Netherlands
Primary and secondary hepatitis prevention and control programmes The Netherlands Irene Veldhuijzen, PhD Public Health Service Rotterdam-Rijnmond Summit Conference Hepatitis B and C Brussels, 14-15 October
Viral Hepatitis. WHO Regional Office for Europe July 2013
Viral Hepatitis WHO Regional Office for Europe July 2013 What is Hepatitis? Hepatitis is a viral infection that causes inflammation of the liver There are five main types of viral hepatitis: A, B, C, D,
Formative Research results
FRR Annex 5: Presentation of the FR results in the project meeting, Berlin, 11. 13.02.2013 Formative Research results Sandra Dudareva Vizule, Ulrich Marcus Robert Koch Institute 11 February 2013 Content
Promoting hepatitis B vaccination
Promoting hepatitis B vaccination Introduction Hepatitis B is a serious blood borne infection that can exacerbate hepatitis C infection, can cause serious liver damage and sometimes results in death. Hepatitis
Using Rapid Assessment and Response Methodology: Waterloo Region's Experience Ontario Harm Reduction Distribution Program Conference
Using Rapid Assessment and Response Methodology: Waterloo Region's Experience Ontario Harm Reduction Distribution Program Conference February 12, 2013 Before we begin Who has completed, or been involved
Poland nationalupdate
Poland nationalupdate 16th October 2014 Annual expert meeting on Drug-related deaths (DRD) and Drug-related infectious diseases (DRID) Estimation of HIV and HCV prevalence among injecting drug users in
Access to needle and syringe exchange services in Estonia
Access to needle and syringe exchange services in Estonia presented by Aljona Kurbatova prepared by Aire Trummal (initially prepared for the workshop How do we know what works? (BZgA, WHO), Berlin, 23.10.2008)
Situation with HIV prevention among MSM in Latvia
Situation with HIV prevention among MSM in Latvia Antons Mozalevskis, M.D. Association of LGBT and their Friends Mozaika mozalevskis@gmail.com office@mozaika.lv The second meeting of the NDPHS Expert Group
New Brunswick Report on Sexually Transmitted and Blood Borne Infections, 2016
New Brunswick Report on Sexually Transmitted and Blood Borne Infections, 6 Table of Contents. Introduction.... Methodology... 3. Data Limitations.... Definitions used... 3 5. Overview of STBBI epidemiology
SUMMARY OF INTERIM REPORT
EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL EXECUTIVE AGENCY FOR HEALTH AND CONSUMERS Health unit SUMMARY OF INTERIM REPORT Title: Empowering Civil Society and Public Health System to
Prevalence of HIV and risk behaviors among injecting drug users in Tallinn, Estonia in a series of cross-sectional studies
Prevalence of HIV and risk behaviors among injecting drug users in Tallinn, Estonia in a series of cross-sectional studies Sigrid Vorobjov 1, Maris Salekešin 1, Katri Abel-Ollo 1, Anneli Uusküla 2, Don
No Wrong Door Integrative Screener 1.0 Feedback Sheet 01/14/15
Name: Derek S. ID: Date: DOB: 07/10/95 Age: 19 Agency: 01/14/15 Demographic Information Age (in years): Country of Origin: Primary Language: Length of Time Living in US (if not born in US): Sex Assigned
NYS PrEP Programming. Lyn Stevens, NP, MS, ACRN Office of the Medical Director, AIDS Institute PrEP Monitoring in NYC and NYS February 19, 2016
NYS PrEP Programming March 21, 2016 Lyn Stevens, NP, MS, ACRN Office of the Medical Director, AIDS Institute PrEP Monitoring in NYC and NYS February 19, 2016 March 21, 2016 2 New York State Priorities
Needle exchange programs
Needle exchange programs What science tells us about needle exchange programs Kerstin Käll, MD, PhD University of Linköping, Sweden Klas Rönnbäck, Ulrich Hermansson, Sten Rönnberg HIV and Injecting Drug
Request for Proposals for a Clean Syringe Exchange Program
ANNA M. ROTH, RN, MS, MPH HEALTH SERVICES DIRECTOR DAN PEDDYCORD, RN, MPA/HA DIRECTOR OF PUBLIC HEALTH C O N T R A C O S T A P U B L I C H E A L T H 597 CENTER AVENUE, SUITE 200 MARTINEZ, CALIFORNIA 94553
HIV, HBV and HCV testing policy experiences and lessons learned.
HIV, HBV and HCV testing policy experiences and lessons learned. Contents HIV and viral hepatitis: distinct epidemics at different stages of evolution Epidemiology: transmission, prevalence, incidence
Update on Community-based harm reduction services in Nelson Mandela Bay 25/10/2018
Update on Community-based harm reduction services in Nelson Mandela Bay 25/10/2018 Overview Background to injecting drug use Overview of harm reduction Data on Hepatitis Summary of services provided by
Prevention Point Philadelphia
Integrating Hepatitis C Prevention, Care, Education, and Referrals in a Clinical & Social Service Setting By Iredia Olaye Primary Care & HCV Outreach, Linkage & Referral Specialist Prevention Point Philadelphia
FIGHTING HIV IN ESTONIA IN 2006 AND Aire Trummal, Liilia Lõhmus, Kristi Rüütel
FIGHTING HIV IN ESTONIA IN 2006 AND 2007 Aire Trummal, Liilia Lõhmus, Kristi Rüütel Tallinn 2008 TABLE OF CONTENTS INTRODUCTION... 3 1. TRENDS OF HIV TRANSMISSION IN ESTONIA... 4 2. STRUCTURES FOR IMPLEMENTING
THE REPUBLIC OF BELARUS
THE REPUBLIC OF BELARUS National Report on the Follow-up to the UNGASS Declaration of Commitment on HIV/AIDS Reporting period: January 2003 December 2005 Minsk 2005 TABLE OF CONTENTS 1. Situation at a
China Country Advocacy Brief Injecting Drug Use and HIV
United Nations Regional Task Force on Injecting Drug Use and HIV/AIDS for Asia and the Pacific China Country Advocacy Brief Injecting Drug Use and HIV Key actions to be supported Expansion of the national
Opportunities For Hepatitis C Modalities in Substance Use Treatment Settings
Opportunities For Hepatitis C Modalities in Substance Use Treatment Settings KATIE BURK, MPH VIRAL HEPATITIS COORDINATOR SAN FRANCISCO DEPARTMENT OF PUBLIC HEALTH 1 Webinar Outline 1. HCV Overview 2. SFDPH
EMCDDA-update HIV/HCV among people who inject drugs: situation and response
EMCDDA-update HIV/HCV among people who inject drugs: situation and response Dagmar Hedrich EU Think Tank HIV/AIDS: 24-25 November 2015, Luxembourg Latest European overview Multi-indicator based analysis
EG on Prison Health Third Meeting Paris France June 2007
EG on Prison Health Third Meeting Paris France 18-19 June 2007 Reference PH 3/7/3/ Title Submitted by Summary / Note Requested action Ongoing and Future Projects in Penal Institutions of Lithuania - For
In 1993 and 1996, 1 percent of IV drug users tested were positive. In 2000, 193 injecting drug users were screened and none tested positive.
24 Update Kuwait 2 Kuwait HIV/AIDS estimates In 23 and during the first quarter of 24, UNAIDS and WHO worked closely with national governments and research institutions to recalculate current estimates
Getting There: Community Policing to Police Social Responsibility Law enforcement & HIV prevention
Getting There: Community Policing to Police Social Responsibility Law enforcement & HIV prevention Soumen Mitra Inspector General of Police CID Calcutta India Perception in conflict The burden of the badge
Building a New Approach to Health Care Services for Hard to Reach Clients
Building a New Approach to Health Care Services for Hard to Reach Clients Community Discussion and Open House January 30, 2013 Fernwood Community Association 1923 Fernwood Street February 6, 2013 North
OF THE REPUBLIC OF ARMENIA DECREE. 316 of 1 April 2002 Yerevan
Ratified President of the Republic of Armenia R. Kocharyan 1 April 2002 GOVERNMENT OF THE REPUBLIC OF ARMENIA DECREE 316 of 1 April 2002 Yerevan On ratification of the National Programme on HIV/AIDS Prevention
POLICY, LEGISLATION, ECONOMIC ANALYSIS AND MEDIA COVERAGE. Last data available Indicator (sphere)
POLICY, LEGISLATION, ECONOMIC ANALYSIS AND MEDIA COVERAGE Amendments in laws and legal regulations number 8 2 NDC Expenditures for activities against drugs and drug addictions in Bulgaria [1] BGN 1 102
Public drug policies Catalonia
Public drug policies Catalonia Public Health Agency of Catalonia Xavier Majó Roca Catalonia Barcelona Territory: 32.000 km2 Population: 7.523.000 M Own language and culture 1. What s happened in Catalonia
Provincial Infectious Diseases Advisory Committee Public Health Response to Hepatitis C
Provincial Infectious Diseases Advisory Committee Public Health Response to Hepatitis C Dr. Doug Sider, Medical Director, Public Health Ontario Dr. Peggy Millson, Professor Emeritus, Dalla Lana School
Prevention and control of viral hepatitis: Role and impact of liver patient groups in Europe. The Netherlands National hepatitis Centre
Prevention and control of viral hepatitis: Role and impact of liver patient groups in Europe. The Netherlands National hepatitis Centre 1) History of the organisation(s) Founded in 1997 by: Dutch liver
Prevention of and Immunisation against Hepatitis B and C
Prevention of and Immunisation against Hepatitis B and C January 2014 Quality Education for a Healthier Scotland 1 Learning Outcomes Participants will be able to:- Demonstrate an increased knowledge and
Figure 1: Newly diagnosed HIV-cases and total number of HIV-cases, (Data source: Estonian Health Board)
UNGASS narrative report, Estonia INTRODUCTION Estonia is the smallest of the three Baltic countries with a population of approximately 1.37 million people and the percentage of non-ethnic Estonians of
Drug demand reduction and harm reduction: complementary approaches. Gilberto Gerra Chief Global Challenges Section Division for Operations
Drug demand reduction and harm reduction: complementary approaches Gilberto Gerra Chief Global Challenges Section Division for Operations The comprehensive approach: no contrast, but synergism, between
As a result of this training, participants will be able to:
Addressing Prevention with HIV Positive Clients 1 Day Training This one-day training will prepare participants to help people living with HIV to avoid sexual and substance use behaviors that can result
Background: Kirketon Road Centre
AN INTEGRATED PRIMARY HEALTH CARE SERVICE IS EFFECTIVE AT RETAINING AND LINKING MARGINALISED GROUPS IN HEPATITIS C CARE: A STUDY OF THE KIRKETON ROAD CENTRE, KINGS CROSS 10 th Australasian Viral Hepatitis
Harm reduction among drug users in Spain
Harm reduction among drug users in Spain Luxemburg,, 27 October 21 Dr. José Manuel Arroyo Cobo Deputy Director General of Health in Prisons Ministry of Internal Affairs Dr. Tomás s Hernández ndez Fernández
OST saves lives it s official! OST a key to HIV prevention Opioid Substitution Treatment in Germany A Story of Success
XVIII International AIDS Conference, 2010 Vienna UNODC-GTZ Satellite Symposium: OST saves lives it s official! OST a key to HIV prevention Opioid Substitution Treatment in Germany A Story of Success Joerg
Achieving the first 90 and doing it right
Achieving the first 90 and doing it right INTEREST Meeting, Cameroon, May 2016 Elizabeth Marum, PhD US Centers for Disease Control and Prevention, Center for Global Health Division of Global HIV and TB
Version for the Silent Procedure 29 April Agenda item January Hepatitis
Version for the Silent Procedure 29 April 2014 134th session EB134.R18 Agenda item 10.5 25 January 2014 Hepatitis The Executive Board, Having considered the report on hepatitis, 1 RECOMMENDS to the Sixty-seventh
Drug Use, Prisons and Compulsory Drug Treatment Centers
Drug Use, Prisons and Compulsory Drug Treatment Centers Sonia Bezziccheri, UNODC Regional Centre for East Asia and the Pacific Thai Satellite Meeting 19 April, 2009 Background In Thailand, drug offences
UNGASS Declaration of Commitment on HIV/AIDS: Core Indicators revision
UNGASS Declaration of Commitment on HIV/AIDS: Core Indicators revision Updated version following MERG recommendations Context In light of country reports, regional workshops and comments received by a
2004 Update. Georgia
24 Update Georgia 2 Georgia HIV/AIDS estimates In 23 and during the first quarter of 24, UNAIDS and WHO worked closely with national governments and research institutions to recalculate current estimates
Intensified TB case finding among PLHIV and vulnerable population Identifying contacts Gunta Kirvelaite
Intensified TB case finding among PLHIV and vulnerable population Identifying contacts Gunta Kirvelaite Riga East Clinical hospital, Centre for tuberculosis and lung diseases. Head of outpatient department.
TARGET INTERVENTION (SIMS Reporting Indicator Definitions)
TARGET INTERVENTION (SIMS Reporting Indicator Definitions) One of the most critical programme elements of NACP III is the provision of targeted prevention interventions for high risk groups and male bridge
Reducing Harm or Producing Harm? Public Health Implications of Prosecuting HIV-positive People. Warren Michelow
Reducing Harm or Producing Harm? Public Health Implications of Prosecuting HIV-positive People Warren Michelow University of British Columbia School of Population and Public Health Outline Prosecuting
increased efficiency. 27, 20
Table S1. Summary of the evidence on the determinants of costs and efficiency in economies of scale (n=40) a. ECONOMETRIC STUDIES (n=9) Antiretroviral therapy (n=2) Scale was found to explain 48.4% of
Guidelines For Services Providing Injecting Equipment
Guidelines For Services Providing Injecting Equipment Best Practice Recommendations For Commissioners and Injecting Equipment Provision (IEP) Services in Scotland (Scottish Government 2010) January 2014
Harm Reduction in Nigeria
Harm Reduction in Nigeria Needs, gaps, and responses to ensure access to effective HIV prevention, treatment and care for people who inject drugs February 2018 This document is made possible by the generous
Background. Population/Intervention(s)/ Comparison/Outcome(s) (PICO)
updated 2012 Role of sterile injection equipment and outreach programmes for injecting drug users Q 6. Does the provision of sterile injection equipment to injecting drug users reduce injecting related
As a result of this training, participants will be able to:
Addressing Sexual Risk with Drug Users and their Partners 1 Day Training This one-day training will build participant knowledge and skills in offering sexual harm reduction options to substance users.
FDAP Drug & Alcohol Professional Certification Workplace Assessment
DANOS AB2 Support individuals who are substance users This unit is about supporting individuals who are substance users by enabling them to adopt safe practices, providing care and support following an
Hepatitis and HIV Co-Infection: Situation in Ukraine.
2nd Central and Eastern European Meeting on Viral Hepatitis and Co-Infection with HIV Hepatitis and HIV Co-Infection: Situation in Ukraine. Pavlo Skala Associate Director: Policy & Partnership Ukraine
Annex A: Impact, Outcome and Coverage Indicators (including Glossary of Terms)
IMPACT INDICATORS (INDICATORS PER GOAL) HIV/AIDS TUBERCULOSIS MALARIA Reduced HIV prevalence among sexually active population Reduced HIV prevalence in specific groups (sex workers, clients of sex workers,